RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
 Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Research Article
Latest Research Channel

subscribe to Latest Research newsletter
Latest Research

   EMAIL   |   PRINT
Grant to study if early BPA exposure leads to late prostate cancer

Feb 20, 2008 - 5:00:00 AM
The study may also lead to improved methods of screening men who may already be at risk, Prins said.

 
[RxPG] Does exposure of baby boys -- in utero or in infancy -- to bisphenol A, a man-made chemical which mimics natural estrogens, predispose them to prostate cancer later in life?

A five-year, $2.6 million grant to a University of Illinois at Chicago researcher and her colleague aims to answer this question by shedding light on the mechanism by which it may occur.

Gail Prins, professor of urology at the UIC College of Medicine and lead investigator on the grant, and her colleague, Shuk-Mei Ho, professor and chair of environmental health at the University of Cincinnati, established in earlier studies in animals that perinatal exposure to BPA at very low doses results in increased sensitivity to estrogen as the male animal ages and an increased risk of developing prostate cancer.

Demonstrating a similar link in humans in an epidemiological study is difficult because of the small dosages and long lag time between exposure and effect. With the new grant, from the National Institute of Environmental Health Sciences, Prins and Ho will attempt to unravel the genetic mechanism by which the dose-response effect in animals is thought to occur.

Scientists think that sensitization to estrogen due to a much earlier exposure to an estrogen-like compound is an epigenetic phenomenon -- a heritable change in gene function that occurs without a change in the DNA sequence, as in mutation.

In this model, the early environment of the fetus causes chemical changes in DNA, called imprinting, which may cause later changes in gene expression. These epigenetic changes, which result in increased or decreased expression of a gene -- or changes in the type of tissues in which the gene is expressed -- can have profound affects on the development of an organism, Prins said. And there is increasing evidence that these changes may be implicated in the origin of a number of adult diseases, like prostate cancer.

We hypothesize that early 'imprinting' of the prostate gland by exposure to small doses of BPA is the result of specific modifications which permanently affect gene expression in the gland, Prins said.

As men age, they produce less testosterone and relatively more estrogen. Our work with animals has shown that exposure of the 'BPA-imprinted' prostate gland to this more estrogen-rich environment is the key to the heightened risk of developing cancer.

BPA is a key chemical in the production of polycarbonate plastic and epoxy resins and is found in products ranging from baby bottles to tin can linings. BPA may break down and leach into food or beverages when it is heated. More than a billion pounds of BPA is produced in the United States each year. The U.S. Centers for Disease Control and Prevention has found BPA in 92 percent of Americans age six or older.

The new study will work with both an animal model and human prostate-like structures and is designed to characterize the dose-response and the period of susceptibility in the developing male, to determine which genes are modified and turned on or off as a result. The researchers also plan to test directly whether the epigenetically modified genes play an active role in the later development of cancer of the prostate gland.

It's our hope that the findings of this study will serve as a model for human exposures to prevalent environmental hormonal disruptors with suspected carcinogenic potential, said Prins.

The study may also lead to improved methods of screening men who may already be at risk, Prins said.

In addition to increasing our understanding of how BPA affects these changes on a molecular level, identification of the specific gene modifications caused by early exposure to BPA may provide us with biomarkers for identifying men at higher risk for prostate cancer as a result of environmental exposures, said Prins.




Advertise in this space for $10 per month. Contact us today.


Related Latest Research News


Subscribe to Latest Research Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)